Bachem Holding AG
A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.
BANB | SW
Overview
Corporate Details
- ISIN(s):
- CH1176493729
- LEI:
- 506700S81111XI7TG884
- Country:
- Switzerland
- Address:
- Hauptstrasse 144, 4416 Bubendorf
- Website:
- https://www.bachem.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Bachem Holding AG is a leading, technology-driven biochemical company specializing in the development and manufacture of peptides and oligonucleotides. With over 50 years of experience, the company operates as a Contract Development and Manufacturing Organization (CDMO), providing a comprehensive portfolio of products and services to the global pharmaceutical and biotechnology industries. Bachem supports its clients throughout the entire lifecycle of their products, from research and clinical development to the large-scale commercial production of complex organic molecules and Active Pharmaceutical Ingredients (APIs).
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Bachem Holding AG and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-20 02:00 |
Board/Management Information
Bachem expands Corporate Executive Committee to include Chief Operations Office…
|
English | 5.3 KB | ||
| 2025-08-20 02:00 |
Board/Management Information
Bachem erweitert Konzernleitung um die Rolle des Chief Operations Officer
|
German | 5.8 KB | ||
| 2025-07-24 02:00 |
Earnings Release
Bachem shows strong growth in the first half of 2025
|
English | 10.8 KB | ||
| 2025-07-24 02:00 |
Earnings Release
Bachem mit starkem Wachstum im ersten Halbjahr 2025
|
German | 12.1 KB | ||
| 2025-06-03 02:00 |
Regulatory News Service
Bachem mourns the loss of company founder Dr. h.c. Peter Grogg
|
English | 4.7 KB | ||
| 2025-06-03 02:00 |
Board/Management Information
Bachem trauert um Firmengründer Dr. h.c. Peter Grogg
|
German | 7.7 KB | ||
| 2025-02-27 01:00 |
Earnings Release
Bachem increases sales and profitability
|
English | 9.7 KB | ||
| 2025-02-27 01:00 |
Earnings Release
Bachem erhöht Umsatz und Profitabilität
|
German | 11.3 KB | ||
| 2024-07-25 02:00 |
Report Publication Announcement
Bachem with slight sales growth in the first half of 2024. Outlook confirmed fo…
|
English | 7.9 KB | ||
| 2024-07-25 02:00 |
Report Publication Announcement
Bachem mit leichtem Umsatzplus im ersten Halbjahr 2024. Ausblick für das Gesam…
|
German | 8.5 KB | ||
| 2024-05-28 02:00 |
Legal Proceedings Report
Incident on construction site of Bachem in Bubendorf
|
English | 2.9 KB | ||
| 2024-05-28 02:00 |
Legal Proceedings Report
Vorfall auf Baustelle der Bachem in Bubendorf
|
German | 3.1 KB | ||
| 2024-04-24 02:00 |
Post-Annual General Meeting Information
Bachem Annual General Meeting 2024
|
English | 3.8 KB | ||
| 2024-04-24 02:00 |
Post-Annual General Meeting Information
Bachem - Ordentliche Generalversammlung 2024
|
German | 4.1 KB | ||
| 2024-03-07 01:00 |
Earnings Release
Bachem continues to grow and increases dividend
|
English | 9.7 KB |
Automate Your Workflow. Get a real-time feed of all Bachem Holding AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Bachem Holding AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-06 | N/A | Non-Executive member | Buy | None | 30,315.25 CHF |
